Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

Summary

The objective of this study is to determine safety and efficacy of silodosin, which is a treatment for benign prostatic hyperplasia with high selectivity to α1A-receptor, on patients with benign prostatic hyperplasia accompanied by nocturia.

Timeline

Start

2014-01-02

Primary completion

2016-03-02

Completion

2016-08-01

Drugs

Indications